ADVANCES IN PRECISION MEDICINE FOR CANCER TREATMENT
DOI:
https://doi.org/10.71465/bhsr57Keywords:
Precision medicine, Cancer treatment, Genomics, Immunotherapy, Targeted therapy, Artificial intelligenceAbstract
Precision medicine is revolutionizing cancer treatment by tailoring therapeutic strategies to the genetic and molecular profiles of individual patients. This approach enhances treatment efficacy, minimizes adverse effects, and optimizes patient outcomes. This paper explores recent advancements in precision oncology, including genomic sequencing, targeted therapies, immunotherapy, and artificial intelligence driven treatment models. We analyze current challenges, future perspectives, and the impact of personalized medicine on clinical oncology. The integration of bioinformatics and big data analytics is also discussed, showcasing the potential of emerging technologies in refining cancer therapeutics.
References
Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793-795.
Garraway LA, Verweij J, Ballman KV. Precision oncology: an overview. J Clin Oncol. 2013;31(15):1803-1805.
Koboldt DC, Steinberg KM, Larson DE, et al. The next-generation sequencing revolution and its impact on genomics. Nat Rev Genet. 2013;15(2):57-64.
Ferrero E, Dunand-Sauthier I, Marçais A, et al. Precision oncology: novel molecular diagnostics. Lancet Oncol. 2020;21(3):e140-e148.
Baselga J. Targeting the phosphoinositide 3-kinase pathway in cancer therapy. Nat Rev Cancer. 2017;17(7):471-485.
Sawyers CL. Cancer: mixed signals in the oncogenic process. Nature. 2008;452(7187):548-552.
Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252-264.
June CH, O'Connor RS, Kawalekar OU, et al. CAR T cell immunotherapy for human cancer. Science. 2018;359(6382):1361-1365.
Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115-118.
Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44-56.
Ginsburg GS, Phillips KA. Precision medicine: from science to value. Health Aff. 2018;37(5):694-701.
Vogenberg FR, Isaacson Barash C, Pursel M. Personalized medicine: part 1: evolution and development into theranostics. Pharm Ther. 2010;35(10):560-576.
Ledford H. Big data: are we making too much of a revolution? Nature. 2014;509(7499):241-242.
Abul-Husn NS, Kenny EE. Personalized medicine and the power of electronic health records. Cell. 2019;177(1):58-69.
Kaestner L, Behrens HM, Roth W, et al. Novel diagnostic approaches in precision oncology. BMC Cancer. 2020;20(1):1-12.
Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350-1355.
Shay JW. Role of telomeres and telomerase in aging and cancer. Cancer Discov. 2016;6(6):584-593.
Chen, N., Zhang, C., An, W., Wang, L., & others. (2025).
Event-based motion deblurring with blur-aware reconstruction filter. IEEE Transactions on Circuits and Systems for Video Technology, PP(99), 1–1. https://doi.org/10.1109/TCSVT.2025.3551516
Yang, P., Snoek, C. G. M., & Asano, Y. M. (2023). Self-Ordering Point Clouds. In Proceedings of the IEEE/CVF International Conference on Computer Vision (ICCV) (pp. 15813–15822). IEEE/CVF. https://doi.org/10.1109/ICCV51070.2023.01449
Yang, P., Mettes, P., & Snoek, C. G. M. (2021). Few‐Shot Transformation of Common Actions Into Time and Space. In Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) (pp. 16031–16040). IEEE/CVF.
Yang, P., Asano, Y. M., Mettes, P., & Snoek, C. G. M. (2022). Less Than Few: Self-Shot Video Instance Segmentation. In European Conference on Computer Vision (ECCV) (pp. ...). Springer / ECCV.
Ahmad, N. R. (n.d.). AI-enabled public governance in developing states: Service delivery gains, accountability risks, and a practical risk-based regulatory model. https://doi.org/10.52152/wja5db40
Ahmad, N. R. (n.d.). Digital marketing strategies and consumer engagement: A comparative study of traditional vs. e-commerce brands. https://doi.org/10.59075/t8pba787
Ahmad, N. R. (n.d.). Digital transformation and competitive advantage: Leveraging AI in emerging market supply chains.
Ahmad, N. R. (n.d.). Sustainable business strategies for achieving competitive advantage in Pakistan’s developing economy. https://doi.org/10.63878/qrjs361
Aamir, A. A. (2025). A unique model of governance and market accessibility: How PSBA stands apart from all other public welfare bodies in Pakistan. https://doi.org/10.52131/pjhss.2025.v13i2.2941
Abbas, S. A. (n.d.). Legislative backing and structural authority: Strengthening corporate governance in emerging market institutions. https://doi.org/10.63878/aaj873
Hussain, T. (n.d.). Market thinking in public service: Designing statutory authorities for governance and efficiency. https://doi.org/10.63878/cjssr.v3i4.1346
Idrees, Z. (n.d.). A distinctive governance model: How Punjab Model Bazaars provide daily essentials below official price ceilings. https://doi.org/10.47067/real.v7i4.435
Sarwar, S. (2025). Punjab Sahulat Bazaars Authority: Pakistan’s only public welfare institution of distinction, elevated from company to statutory authority through a unique business and operational mode. https://doi.org/10.52131/pjhss.2025.v13i3.2943
Shahzad, K. (2025). Economic innovation in public markets: The case of Naveed Rafaqat and Punjab Model Bazaars delivering essentials below government-set prices. https://doi.org/10.52131/pjhss.2025.v13i1.2942
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Hina Qureshi (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the Bulletin of Health Services Research are open access and distributed under the terms of the Creative Commons Attribution License. This permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Authors retain copyright, and the journal ensures free and permanent access to published content.
